207 related articles for article (PubMed ID: 37331449)
1. Liangxue Jiedu formula improves imiquimod-induced psoriasiform dermatitis with circadian desynchrony by regulating Th17 cell differentiation based on network pharmacological analysis.
Xie X; Zhang L; Lin Y; Liu X; Han X; Li P
J Ethnopharmacol; 2023 Dec; 317():116807. PubMed ID: 37331449
[TBL] [Abstract][Full Text] [Related]
2. Liangxue Jiedu Formula Improves Psoriasis and Dyslipidemia Comorbidity
Xie X; Zhang L; Li X; Liu W; Wang P; Lin Y; Han X; Li P
Front Pharmacol; 2021; 12():591608. PubMed ID: 33762935
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the mechanism of Fang-Ji-Di-Huang-Decoction in ameliorating psoriasis-like skin inflammation via the inhibition of IL-23/Th17 cell axis.
Song C; Yang C; Meng S; Li M; Wang X; Zhu Y; Kong L; Lv W; Qiao H; Sun Y
J Ethnopharmacol; 2021 Dec; 281():114571. PubMed ID: 34464701
[TBL] [Abstract][Full Text] [Related]
4. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
Ma L; Xue H; Qi R; Wang Y; Yuan L
J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
[TBL] [Abstract][Full Text] [Related]
5. MAD ointment ameliorates Imiquimod-induced psoriasiform dermatitis by inhibiting the IL-23/IL-17 axis in mice.
OuYang Q; Pan Y; Luo H; Xuan C; Liu J; Liu J
Int Immunopharmacol; 2016 Oct; 39():369-376. PubMed ID: 27540765
[TBL] [Abstract][Full Text] [Related]
6. Potential shared therapeutic and hepatotoxic mechanisms of Tripterygium wilfordii polyglycosides treating three kinds of autoimmune skin diseases by regulating IL-17 signaling pathway and Th17 cell differentiation.
Chen Y; Wang YF; Song SS; Zhu J; Wu LL; Li XY
J Ethnopharmacol; 2022 Oct; 296():115496. PubMed ID: 35750104
[TBL] [Abstract][Full Text] [Related]
7. Rosmarinic acid protects mice from imiquimod induced psoriasis-like skin lesions by inhibiting the IL-23/Th17 axis via regulating Jak2/Stat3 signaling pathway.
Zhang M; Li N; Cai R; Gu J; Xie F; Wei H; Lu C; Wu D
Phytother Res; 2021 Aug; 35(8):4526-4537. PubMed ID: 34008239
[TBL] [Abstract][Full Text] [Related]
8. Anti-IL-17A and IL-23p19 antibodies but not anti-TNFα antibody induce expansion of regulatory T cells and restoration of their suppressive function in imiquimod-induced psoriasiform dermatitis.
Shimizu T; Kamata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
J Dermatol Sci; 2019 Sep; 95(3):90-98. PubMed ID: 31362906
[TBL] [Abstract][Full Text] [Related]
9. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of IL-27 in moderate-to-severe psoriasis and its anti-inflammation role in imiquimod-induced psoriasis-like mouse model.
Chen W; Gong Y; Zhang X; Tong Y; Wang X; Fei C; Xu H; Yu Q; Wang Y; Shi Y
J Dermatol Sci; 2017 Feb; 85(2):115-123. PubMed ID: 27939414
[TBL] [Abstract][Full Text] [Related]
11. Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation.
Shokrian Zeini M; Haddadi NS; Shayan M; Shokrian Zeini M; Kazemi K; Solaimanian S; Abdollahifar MA; Hedayatyanfard K; Dehpour AR
Int Immunopharmacol; 2021 Nov; 100():108160. PubMed ID: 34583123
[TBL] [Abstract][Full Text] [Related]
12. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
13. Apremilast downregulates interleukin-17 production and induces splenic regulatory B cells and regulatory T cells in imiquimod-induced psoriasiform dermatitis.
Uchida H; Kamata M; Shimizu T; Egawa S; Ito M; Takeshima R; Mizukawa I; Watanabe A; Tada Y
J Dermatol Sci; 2021 Oct; 104(1):55-62. PubMed ID: 34548208
[TBL] [Abstract][Full Text] [Related]
14. [Esculentoside reduces expression of Th17 cell-related cytokines in the imiquimod-induced psoriasis-like dermatitis mouse model].
Lyu R; Feng F; Feng Z; Ma T; Lyu R
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Jul; 35(7):595-600. PubMed ID: 31537243
[TBL] [Abstract][Full Text] [Related]
15. Gentiopicroside-Loaded Chitosan Nanoparticles Inhibit TNF-α-Induced Proliferation and Inflammatory Response in HaCaT Keratinocytes and Ameliorate Imiquimod-Induced Dermatitis Lesions in Mice.
Zhao K; Pu S; Sun L; Zhou D
Int J Nanomedicine; 2023; 18():3781-3800. PubMed ID: 37457802
[TBL] [Abstract][Full Text] [Related]
16. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways.
Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H
J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840
[TBL] [Abstract][Full Text] [Related]
17. Decryption of Active Constituents and Action Mechanism of the Traditional Uighur Prescription (BXXTR) Alleviating IMQ-Induced Psoriasis-Like Skin Inflammation in BALB/c Mice.
Pang X; Zhang K; Huang J; Wang H; Gao L; Wang T; Sun Y; Chen L; Wang J
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29933541
[TBL] [Abstract][Full Text] [Related]
18. [Effect of fire needling on imiquimod induced psoriasis-like lesion and STAT3 pathway in mice].
Feng F; Wang Y; Zhao JX; Di TT; Meng YJ; Chen ZX; Qi C; Hu XQ; Wang YZ; Li P
Zhongguo Zhen Jiu; 2022 May; 42(5):541-8. PubMed ID: 35543945
[TBL] [Abstract][Full Text] [Related]
19. Combining network pharmacology, RNA-seq, and metabolomics strategies to reveal the mechanism of Cimicifugae Rhizoma - Smilax glabra Roxb herb pair for the treatment of psoriasis.
Hu X; Qi C; Feng F; Wang Y; Di T; Meng Y; Wang Y; Zhao N; Zhang X; Li P; Zhao J
Phytomedicine; 2022 Oct; 105():154384. PubMed ID: 35963195
[TBL] [Abstract][Full Text] [Related]
20. Anti-psoriasis effect of water-processed rosin in mice.
Li XQ; Chen Y; Zhou HM; Shi HL; Yan XN; Lin LP; Tan RX
J Ethnopharmacol; 2019 Oct; 242():112073. PubMed ID: 31288049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
